Morphological chest CT changes in cystic fibrosis and massive hemoptysis

Background Massive hemoptysis (MH) is a rare but potentially life-threatening condition of patients with mainly advanced cystic fibrosis (CF). Morphological lung changes are aggravated with disease progression. The aim of this study was to determine whether morphological lung changes differ between patients with CF (pwCF) who have MH and pwCF without MH. Methods Chest computed tomography (CT) scans of pwCF and MH acquired at a maximum of 4 months prior to MH (1/2008 to 2/2015) were evaluated for morphological changes and bronchial artery (BA) diameters. Lung lobes with MH were compared with lobes without MH and with matched control patients with end-stage CF and no hemoptysis using the Helbich scoring system. Results The study included 26 patients with MH (P MH ; 15 female, median age 29 years, interquartile range [IQR]: 25–33.75) and 17 matched control patients (11 male, median age 24 years, IQR: 19.5–30). No difference in Helbich score was detected between lobes with MH and matched control patients ( p = 0.051). Higher scores were detected in lobes with MH compared to lobes without MH in P MH ( p = 0.021), but no difference was detected in the subscores. The BA diameters were larger in P MH ( p = 0.02); 85% of P MH had unilateral MH, with 65% of MH involving only one or two lobes. Conclusion Morphological changes are more severe in lobes with MH in the same patient, but there is no difference when compared with matched control patients. Besides abscess/sacculation, no specific changes for MH were identified. Other factors such as BA hypertrophy might play a pivotal role in the pathogenesis of MH in pwCF. Commonly used scores to evaluate chest CT in pwCF cannot be used to assess MH, and other factors, e.g., hypertrophied BA, not represented and not measured in these scores, might be more suitable for assessing the risk for MH.